Drug intelligence / Profile preview

ignatia amara

Development stage
Unknown
Lead developer
Boiron
Administration
Oral, Sublingual
01

Overview

Ignatia amara is a homeopathic remedy prepared from the seeds of the Strychnos ignatii plant (commonly called "Ignatius bean"). It is primarily used in homeopathy for relief of emotional distress such as grief, anxiety, hypersensitivity to stress and mood swings. The seeds contain alkaloids including strychnine and brucine that affect the nervous system by influencing nerve impulse transmission to muscles. In homeopathic preparations (high dilutions), it is claimed to help with symptoms like apprehension, irritability, sadness or moodiness often associated with emotional disturbances[1][2][3][4][5]. The product is available as oral pellets or tinctures and marketed for both adults and children. Despite its use in homeopathy at high dilutions considered non-toxic by practitioners[1], the raw plant material itself contains toxic compounds and can be dangerous if ingested directly[7]. There are no established mechanisms of action recognized in conventional pharmacology due to its extreme dilution in homeopathic products.

Other names
Ignatius beanBean of St. IgnatiusFiève de Saint-IgnanceHabas de San IgnacioIgnatiaLu Song GuoSaint Ignatius-beansStrychnos ignatiiStrychnos tieute

Beyond the preview

Go deeper on ignatia amara.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ignatia amara.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call